BRPI0417437A - dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose - Google Patents

dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose

Info

Publication number
BRPI0417437A
BRPI0417437A BRPI0417437-2A BRPI0417437A BRPI0417437A BR PI0417437 A BRPI0417437 A BR PI0417437A BR PI0417437 A BRPI0417437 A BR PI0417437A BR PI0417437 A BRPI0417437 A BR PI0417437A
Authority
BR
Brazil
Prior art keywords
active agent
physiologically active
overdose
agent removal
absorption inhibiting
Prior art date
Application number
BRPI0417437-2A
Other languages
English (en)
Inventor
Andrew Jonathan Humberstone
Nina Frances Wilkins
Igor Gonda
Original Assignee
Acrux Dds Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003906842A external-priority patent/AU2003906842A0/en
Application filed by Acrux Dds Pty Ltd filed Critical Acrux Dds Pty Ltd
Publication of BRPI0417437A publication Critical patent/BRPI0417437A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"DISPOSITIVO PARA INIBIçãO DA ABSORçãO PERCUTáNEA, DISPOSITIVO PARA REMOçãO DE AGENTE FISIOLOGICAMENTE ATIVO E DISPOSITIVO PARA REDUçãO DO EFEITO DE OVERDOSE". A presente invenção se refere a um método para inibição da absorção percutânea de um agente fisiologicamente ativo topicamente aplicado a um local de administração transdérmica de um indivíduo, o método incluindo a etapa de aplicação, à pele do indivíduo, no local de administração transdérmica, de um dispositivo (1, 7) compreendendo uma membrana (8) para contato da pele do indivíduo revestida sobre o lado de contato com a pele do mesmo (11) com uma camada de um adesivo (10).
BRPI0417437-2A 2003-12-10 2004-12-09 dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose BRPI0417437A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003906842A AU2003906842A0 (en) 2003-12-10 Method of treatment for undesired effect following transdermal or topical drug delivery
PCT/AU2004/001738 WO2005056103A1 (en) 2003-12-10 2004-12-09 Method of treatment for undesired effect following transdermal or topical drug delivery

Publications (1)

Publication Number Publication Date
BRPI0417437A true BRPI0417437A (pt) 2007-03-06

Family

ID=34658477

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417437-2A BRPI0417437A (pt) 2003-12-10 2004-12-09 dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose

Country Status (9)

Country Link
US (1) US20070255197A1 (pt)
EP (1) EP1703938A1 (pt)
JP (1) JP2007520262A (pt)
KR (1) KR20060126701A (pt)
CN (1) CN1889994A (pt)
BR (1) BRPI0417437A (pt)
CA (1) CA2548596A1 (pt)
EA (1) EA200601129A1 (pt)
WO (1) WO2005056103A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156465A1 (en) 2005-12-30 2009-06-18 Sattigeri Jitendra A Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
DE102007030710A1 (de) * 2007-07-02 2009-01-08 Robert Bosch Gmbh Vorrichtung zur Aufbewahrung und Verabreichung von Wirkstoffen und ein Verfahren zur Verabreichung von Wirkstoffen mittels einer solchen Vorrichtung
AR068409A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Composiciones farmaceuticas, transdermicas sin alcohol
AR068408A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Pulverizacion de hormonas transdermicas
US20100048598A1 (en) * 2008-08-21 2010-02-25 Sateesh Kandavilli Topical compositions comprising 5-alpha reductase inhibitors
RU2465884C1 (ru) * 2011-08-09 2012-11-10 Борис Николаевич Анисимов Способ комплексного лечения больных с хронической подагрой на курортном этапе
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
WO2014051128A1 (ja) * 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014159798A1 (en) 2013-03-13 2014-10-02 Avery Dennison Corporation Improving adhesive properties
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106512201B (zh) * 2017-01-14 2024-05-28 南京邓迪医疗设备科技有限公司 肺部理疗溶媒缓释装置
CN108186553B (zh) * 2018-02-13 2020-10-02 广东药科大学 一种黄体酮长效栓剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960467A (en) * 1985-02-11 1990-10-02 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
GB8509977D0 (en) * 1985-04-18 1985-05-30 Juhasz L Wound dressings
US4756314A (en) * 1985-10-28 1988-07-12 Alza Corporation Sweat collection patch
US5899856A (en) * 1988-09-08 1999-05-04 Sudormed, Inc. Dermal patch detecting long-term alcohol consumption and method of use
US5441048A (en) * 1988-09-08 1995-08-15 Sudor Partners Method and apparatus for determination of chemical species in perspiration
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
FR2672477B1 (fr) * 1991-02-11 1994-12-02 Salomon Sa Premiere de proprete pour chaussures capable d'absorber la transpiration.
US5840072A (en) * 1993-06-01 1998-11-24 Carey; Martin R. Adhesive tape application to human skin
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
WO1999055341A1 (en) * 1998-04-27 1999-11-04 Elan Pharmaceuticals, Inc. Transdermal administration of fenoldopam
EP1109594B1 (en) * 1998-08-31 2004-10-27 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9826882D0 (en) * 1998-12-07 1999-01-27 Novartis Ag Organic compounds
US6660901B2 (en) * 1999-09-24 2003-12-09 Glenda Church Charcoal skin patch
US20030082219A1 (en) * 2001-10-01 2003-05-01 The Procter & Gamble Company Skin care compositions comprising low concentrations of skin treatment agents
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
FR2840218B1 (fr) * 2002-06-04 2004-08-13 Centre Nat Rech Scient Emulsions simples et multiples destinees a la detoxication de l'organisme ou de surfaces

Also Published As

Publication number Publication date
WO2005056103A1 (en) 2005-06-23
CA2548596A1 (en) 2005-06-23
CN1889994A (zh) 2007-01-03
JP2007520262A (ja) 2007-07-26
EA200601129A1 (ru) 2006-10-27
US20070255197A1 (en) 2007-11-01
KR20060126701A (ko) 2006-12-08
EP1703938A1 (en) 2006-09-27

Similar Documents

Publication Publication Date Title
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
KR101741294B1 (ko) 미소 돌기가 형성된 어레이를 갖는 디바이스
BRPI0510760A (pt) método para administrar a um paciente uma composição, composição tópica, e, emplastro
BR0317743A (pt) Dispositivo de liberação de agente ativo tendo membros de compósito
BRPI0511235A (pt) preparado tópico e método para a administração transdérmica e localização de agentes terapêuticos
BRPI0517501A (pt) dispositivo médico apropriado para uso na administração de um componente ativo na ou através da pele
NO20062434L (no) Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemer
AR048827A1 (es) Aparato y metodo para la administracion transdermica de agentes basados en fentanil
AR046823A1 (es) Sistema y metodo de administracion de vacuna transdermica asistida por ultrasonido
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
AR046697A1 (es) Metodo y sistema de administracion transdermica de agente asistido por frecuencia
BRPI0820581A8 (pt) Dispositivo de interface com paciente, e, cânula nasal
BRPI0415967A (pt) aplicação de conjugados de polìmero de peptìdeos e proteìnas terapêuticos através de microprojeções revestidas
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
BR0016402A (pt) Método para aumentar a permeabilidade da pele ou do tecido mucoso a agentes farmaceuticamente ou cosmeticamente ativos administrados por via tópica ou transdérmica
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
BRPI0415986A (pt) método e aparelho para reduzir a incidência do uso de tabaco
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
NO20062234L (no) Transdemisk,farmasoytisk spray-formulering omfattende en VP/UA kopolymer og en ikke-vandig vehikkel
WO2006065870A8 (en) Topical numbing composition for laser therapy
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.
BR0316275A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2, solúvel em água, por exemplo, parecoxibe e valdecoxibe
BR0316463A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2 solúvel em água, por exemplo, derivados de parecoxib, valdecoxib e benzopirano
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.